Hard targets for a second skeleton: therapeutic horizons for fibrodysplasia ossificans progressiva (FOP)

Frederick S. Kaplan, Robert Pignolo, Mona M. Al Mukaddam, Eileen M. Shore

Research output: Contribution to journalEditorial

13 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)291-294
Number of pages4
JournalExpert Opinion on Orphan Drugs
Volume5
Issue number4
DOIs
StatePublished - Apr 3 2017

Keywords

  • Activin A
  • ACVR1
  • bone morphogenetic protein receptors
  • fibrodysplasia ossificans progressiva
  • heterotopic endochondral ossification
  • hypoxia

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Health Policy
  • Pharmacology (medical)

Cite this

Hard targets for a second skeleton : therapeutic horizons for fibrodysplasia ossificans progressiva (FOP). / Kaplan, Frederick S.; Pignolo, Robert; Al Mukaddam, Mona M.; Shore, Eileen M.

In: Expert Opinion on Orphan Drugs, Vol. 5, No. 4, 03.04.2017, p. 291-294.

Research output: Contribution to journalEditorial

Kaplan, Frederick S. ; Pignolo, Robert ; Al Mukaddam, Mona M. ; Shore, Eileen M. / Hard targets for a second skeleton : therapeutic horizons for fibrodysplasia ossificans progressiva (FOP). In: Expert Opinion on Orphan Drugs. 2017 ; Vol. 5, No. 4. pp. 291-294.
@article{ac4cec4fac964b15acdc3b0f8c2db13e,
title = "Hard targets for a second skeleton: therapeutic horizons for fibrodysplasia ossificans progressiva (FOP)",
keywords = "Activin A, ACVR1, bone morphogenetic protein receptors, fibrodysplasia ossificans progressiva, heterotopic endochondral ossification, hypoxia",
author = "Kaplan, {Frederick S.} and Robert Pignolo and {Al Mukaddam}, {Mona M.} and Shore, {Eileen M.}",
year = "2017",
month = "4",
day = "3",
doi = "10.1080/21678707.2017.1304211",
language = "English (US)",
volume = "5",
pages = "291--294",
journal = "Expert Opinion on Orphan Drugs",
issn = "2167-8707",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Hard targets for a second skeleton

T2 - therapeutic horizons for fibrodysplasia ossificans progressiva (FOP)

AU - Kaplan, Frederick S.

AU - Pignolo, Robert

AU - Al Mukaddam, Mona M.

AU - Shore, Eileen M.

PY - 2017/4/3

Y1 - 2017/4/3

KW - Activin A

KW - ACVR1

KW - bone morphogenetic protein receptors

KW - fibrodysplasia ossificans progressiva

KW - heterotopic endochondral ossification

KW - hypoxia

UR - http://www.scopus.com/inward/record.url?scp=85015680562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015680562&partnerID=8YFLogxK

U2 - 10.1080/21678707.2017.1304211

DO - 10.1080/21678707.2017.1304211

M3 - Editorial

AN - SCOPUS:85015680562

VL - 5

SP - 291

EP - 294

JO - Expert Opinion on Orphan Drugs

JF - Expert Opinion on Orphan Drugs

SN - 2167-8707

IS - 4

ER -